Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -4.087% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) CC(C)C[C@H](N)c1nnc(SCC(=O)Nc2ccc(Br)cc2)o1
b.) Cc1ccccc1NS(=O)(=O)c1ccc(Cl)cc1
Answer: a. CC(C)C[C@H](N)c1nnc(SCC(=O)Nc2ccc(Br)cc2)o1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)C[C@H](N)c1nnc(SCC(=O)Nc2ccc(Br)cc2)o1
CC(C)C[C@H](N)c1nnc(SCC(=O)Nc2ccc(Br)cc2)o1
2-[[5-[(1S)-1-amino-3-methylbutyl]-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(4-bromophenyl)acetamide